Role of erythropoietin in reducing allogeneic transfusions after joint arthroplasty
Preoperative Use of Recombinant Human Erythropoietin Before Total Joint ArthroplastyJ Bone Joint Surg Am. 2003 Sep;85-A(9):1795-800
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
240 patients undergoing arthroplasty of the hip or knee were randomized to preoperatively receive erythropoietin and autologous donation (Group 1), erythropoietin alone (Group 2), or preoperative autologous donation alone (Group 3). Patients were then evaluated postoperatively for allogeneic transfusion requirements, hemoglobin values, and complications or adverse reactions. Patients in Group 1 ha...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue